Skip to main content
Fig. 5 | Trials

Fig. 5

From: Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trial

Fig. 5

Expected distribution of transfused plasma potency. The distribution of mean antibody titre in transfused convalescent plasma units was projected by performing a simulation in which plasma units from different donors were paired randomly. The simulation is based on the titres of 1150 plasma units currently in inventory at one of the blood suppliers (Héma-Québec). Titers were originally established with an in-house ELISA but have been translated in equivalent d/co units from the ORTHO VITRIOS IgG assay

Back to article page